Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors

Clinical trial NCT00096707 · COMPLETED

Trial details

NCT number: NCT00096707
Sponsor: Threshold Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer Breast Cancer Pancreatic Cancer Head and Neck Cancer Gastric Cancer

Start date: 2004-02-01
Primary completion: 2008-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.